These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 21206443)
1. Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? Khazaie H; Rahimi M; Tatari F; Rezaei M; Najafi F; Tahmasian M Neurosciences (Riyadh); 2011 Jan; 16(1):42-5. PubMed ID: 21206443 [TBL] [Abstract][Full Text] [Related]
2. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Lustman PJ; Freedland KE; Griffith LS; Clouse RE Diabetes Care; 2000 May; 23(5):618-23. PubMed ID: 10834419 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Amsterdam JD; Shults J; Rutherford N; Schwartz S Neuropsychobiology; 2006; 54(4):208-14. PubMed ID: 17337914 [TBL] [Abstract][Full Text] [Related]
4. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up. Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027 [TBL] [Abstract][Full Text] [Related]
5. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031 [TBL] [Abstract][Full Text] [Related]
6. Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder. Shahsavand-Ananloo E; Berenji F; Sadeghniiat K; Alimadadi A; Zahiroddin AR; Tabatabaee M; Abbasi-Asl M; Ghaeli P Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1155-61. PubMed ID: 23690183 [TBL] [Abstract][Full Text] [Related]
7. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
8. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Küçükibrahimoğlu E; Saygin MZ; Calişkan M; Kaplan OK; Unsal C; Gören MZ Eur J Clin Pharmacol; 2009 Jun; 65(6):571-7. PubMed ID: 19373461 [TBL] [Abstract][Full Text] [Related]
9. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Goodnick PJ Ann Clin Psychiatry; 2001 Mar; 13(1):31-41. PubMed ID: 11465683 [TBL] [Abstract][Full Text] [Related]
10. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Suvanto-Luukkonen E; Koivunen R; Sundström H; Bloigu R; Karjalainen E; Häivä-Mällinen L; Tapanainen JS Menopause; 2005; 12(1):18-26. PubMed ID: 15668596 [TBL] [Abstract][Full Text] [Related]
11. Hypericum extract LI 160 and fluoxetine in mild to moderate depression: a randomized, placebo-controlled multi-center study in outpatients. Bjerkenstedt L; Edman GV; Alken RG; Mannel M Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):40-7. PubMed ID: 15538592 [TBL] [Abstract][Full Text] [Related]
12. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189 [TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. Luo YL; Zhang MY; Wu WY; Li CB; Lu Z; Li QW Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1522-5. PubMed ID: 19733606 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942 [TBL] [Abstract][Full Text] [Related]
15. Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control. Nicolau J; Rivera R; Francés C; Chacártegui B; Masmiquel L Diabetes Res Clin Pract; 2013 Aug; 101(2):148-52. PubMed ID: 23800573 [TBL] [Abstract][Full Text] [Related]
16. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Pérez V; Gilaberte I; Faries D; Alvarez E; Artigas F Lancet; 1997 May; 349(9065):1594-7. PubMed ID: 9174562 [TBL] [Abstract][Full Text] [Related]
17. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population. Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice. Wolak M; Siwek A; Szewczyk B; Poleszak E; Bystrowska B; Moniczewski A; Rutkowska A; Młyniec K; Nowak G Pharmacol Rep; 2015 Jun; 67(3):490-3. PubMed ID: 25933959 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients. Nemeroff CB; Thase ME; J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158 [TBL] [Abstract][Full Text] [Related]
20. Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits. Sas K; Csete K; Vezekényi Z; Sztriha L; Vécseil L; Papp JG Acta Physiol Hung; 2007 Sep; 94(3):167-77. PubMed ID: 17853768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]